Sign In
Buy EBS
$7.93
-0.280 (-3.41%)
At Close: Jun 03, 2026
Is There Any Hope Left for Emergent BioSolutions?
06:10am, Tuesday, 27'th Apr 2021
The go-to government contractor is in deep trouble. Should investors buy the dip?
New York, New York--(Newsfile Corp. - April 26, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Emergent Biosolutions Inc.Shar
EBS INVESTOR ALERT: Class Action Lawsuit Filed
06:00pm, Monday, 26'th Apr 2021
Boston, Massachusetts--(Newsfile Corp. - April 26, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Emergent BioSolutions Inc. (NYSE:
New York, New York--(Newsfile Corp. - April 26, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Emergent Biosolutions Inc. (NYSE: EBS) al
Boston, Massachusetts--(Newsfile Corp. - April 26, 2021) - Block & Leviton LLP announces that a lawsuit for violations of the federal securities laws has been filed against Emergent BioSolutions Inc.
New York, New York--(Newsfile Corp. - April 26, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of E
CEO of COVID-19 vaccine maker sold $10M in stock before company destroyed Johnson & Johnson doses
01:48pm, Monday, 26'th Apr 2021
The CEO of Emergent BioSolutions, the government contractor that destroyed 15 million doses of Johnson & Johnson's COVID-19 vaccine, sold more than $10 million worth of his stock in the company before
LOS ANGELES, April 26, 2021 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Emergent BioSolutions Inc. ("Eme
A vaccine maker ruined 15 million doses. Its CEO sold $11 million of stock before that was public
12:26pm, Monday, 26'th Apr 2021
Emergent BioSciences' stock lost more than half of its value since the disclosure that it ruined as many as 15 million doses of Johnson & Johnson's Covid-19 vaccine at its Baltimore plant. But the com
RADNOR, Pa., April 26, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court
LOS ANGELES--(BUSINESS WIRE)---- $EBS #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on beh
What's in Store for Emergent (EBS) This Earnings Season?
10:31am, Monday, 26'th Apr 2021
On Emergent's (EBS) upcoming first-quarter earnings call, investors are likely to focus on the company's update related to re-start of production at its Bayview facility.
Moving Average Crossover Alert: Emergent BioSolutions (EBS)
07:31am, Monday, 26'th Apr 2021
Emergent BioSolutions (EBS) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
NEW YORK, April 24, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Emergent Bi
Radnor, Pennsylvania--(Newsfile Corp. - April 24, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United State
